UnitedHealth Group (UNH) to Release Quarterly Earnings on Thursday

Thursday, April 8, 2021 | MarketBeat

UnitedHealth Group (NYSE:UNH) is scheduled to announce its earnings results before the market opens on Thursday, April 15th. Analysts expect the company to announce earnings of $4.41 per share for the quarter. Parties interested in participating in the company's conference call can do so using this link.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, January 19th. The healthcare conglomerate reported $2.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.39 by $0.13. The firm had revenue of $65.47 billion during the quarter, compared to the consensus estimate of $64.98 billion. UnitedHealth Group had a return on equity of 27.53% and a net margin of 6.62%. The business's revenue for the quarter was up 7.5% on a year-over-year basis. During the same period in the prior year, the business earned $3.90 EPS. On average, analysts expect UnitedHealth Group to post $17 EPS for the current fiscal year and $18 EPS for the next fiscal year.

Shares of UNH opened at $365.64 on Thursday. The company has a debt-to-equity ratio of 0.59, a current ratio of 0.82 and a quick ratio of 0.82. The company has a market capitalization of $345.65 billion, a price-to-earnings ratio of 21.00, a P/E/G ratio of 1.55 and a beta of 0.74. The business's 50-day moving average is $351.44 and its 200-day moving average is $339.34. UnitedHealth Group has a fifty-two week low of $246.26 and a fifty-two week high of $380.50.

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 23rd. Shareholders of record on Monday, March 15th were paid a $1.25 dividend. The ex-dividend date was Friday, March 12th. This represents a $5.00 annualized dividend and a yield of 1.37%. UnitedHealth Group's dividend payout ratio is presently 33.09%.

In other news, Director Richard T. Burke sold 4,000 shares of the firm's stock in a transaction that occurred on Monday, March 15th. The shares were sold at an average price of $353.32, for a total transaction of $1,413,280.00. Following the completion of the sale, the director now owns 153,953 shares of the company's stock, valued at $54,394,673.96. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, CAO Thomas E. Roos sold 619 shares of the business's stock in a transaction that occurred on Tuesday, February 9th. The stock was sold at an average price of $323.90, for a total value of $200,494.10. Following the completion of the transaction, the chief accounting officer now directly owns 31,908 shares in the company, valued at $10,335,001.20. The disclosure for this sale can be found here. Over the last three months, insiders sold 9,619 shares of company stock valued at $3,292,774. 0.80% of the stock is currently owned by insiders.

A hedge fund recently bought a new stake in UnitedHealth Group stock. OLD Mission Capital LLC purchased a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH) during the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 1,409 shares of the healthcare conglomerate's stock, valued at approximately $439,000. 86.03% of the stock is owned by institutional investors and hedge funds.

Several research firms have recently commented on UNH. Bank of America restated a "buy" rating and set a $415.00 price target on shares of UnitedHealth Group in a report on Thursday, January 21st. Deutsche Bank Aktiengesellschaft increased their price objective on UnitedHealth Group from $404.00 to $409.00 and gave the stock a "buy" rating in a report on Thursday, January 21st. SVB Leerink increased their price target on shares of UnitedHealth Group from $378.00 to $390.00 and gave the stock an "outperform" rating in a research note on Monday, December 14th. Truist increased their target price on shares of UnitedHealth Group from $400.00 to $420.00 in a research report on Tuesday, January 5th. Finally, Barclays reissued a "buy" rating and set a $405.00 price objective on shares of UnitedHealth Group in a report on Sunday, January 17th. Five equities research analysts have rated the stock with a hold rating, fifteen have issued a buy rating and one has issued a strong buy rating to the company's stock. The company has an average rating of "Buy" and an average price target of $387.82.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, Children's Health Insurance Program, and health care programs; medical and dental benefits; and health care delivery.

Featured Story: Differences Between Momentum Investing and Long Term Investing

Earnings History for UnitedHealth Group (NYSE:UNH)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected]

Featured Article: What is the Dividend Aristocrat Index?

7 Stocks It May Be Time To Take Profits On

Should you or shouldn’t you? Many investors are wondering if it’s time to take some profit. With so much uncertainty in the market, there can be a temptation to take your profits and run. That may or may not be a good strategy. It’s true there are some speculative stocks that are going up on nothing but faith, trust, and pixie dust. But there are other stocks that may still be good buys despite continuing to grow.

Since the sell-off caused by the novel coronavirus and subsequent locking down of large portions of the economy, the stock market has recovered nearly all of its losses. The Federal Reserve has done its part by pledging to keep interest rates low for as long as it takes. New housing starts are up. Unemployment is coming down. There seems to be a lot of fuel for market bulls.

Still, if you’ve been holding one of the stocks in this presentation, it may be time for you to take some of the profits you’ve made. Many of the stocks in this presentation are being downgraded by analysts. And that means that there is likely to be downward pressure on the stock price.

View the "7 Stocks It May Be Time To Take Profits On".

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.